Trial intelligence / Profile preview

HEPOIRINE

2015-003138-28Phase 4Completed

Sponsor
Strasbourg University Hospital
Start
Dec 2015
Modality
Small Molecules, Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, open-label trial of heparin (2 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Heparinemia at t1. Started Dec 2015; status: completed.

02

Drugs

heparin

Beyond the preview

Go deeper on 2015-003138-28.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2015-003138-28.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call